Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 5.6e-05 | 1 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.00018 | 1 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.00013 | 1 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.00042 | 1 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.0046 | 1 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.0052 | 1 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0019 | 1 |